T. Fukami et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF CYCLIC PENTAPEPTIDE ENDOTHELIN-A RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 38(21), 1995, pp. 4309-4324
Analogues of the natural product endothelin A (ET(A)) receptor antagon
ists cyclo(-D-Trp(1)-D-Glu(2) Ala(3)-D-Val(4)-Leu(5)-) (1) and yclo(-D
-Trp(1)-D-Glu(2)-Ala(3)-D-allone(4)-Leu(5)) (2) were prepared and test
ed for inhibitory activity against [I-125]endothelin (ET-1) binding to
protein ET(A) receptors. The DDLDL chirality sequence of the natural
products appeared to be critical for inhibitory activity because conve
rsion of either D-Trp or D-Glu (or both) in 1 to the corresponding L-i
somer(s) abolished this property. Systematic modifications at each pos
ition of the natural products clarified the structure-activity relatio
nships and led to highly potent and selective ET(A) receptor antagonis
ts. Most replacements of D-Trp(1) and Leu(5) with other amino acids ca
used a significant loss of inhibitory activity. In contrast, replaceme
nt of D-Glu(2) with D-Asp(2) enhanced the activity. With regard to the
Ala(3) position, all analogues with imino acids, independent of being
cyclic or acyclic, showed higher affinities than did the amino acid a
nalogues. In addition, most replacements with amino acids, which had v
arious functional groups in their side chains, did not significantly m
odify ET(A) binding affinity. The D-Val(4)/D-alloIle(4) position was v
ery important for inhibitory activity, and a beta-position branched D-
amino acid or a D-heteroarylglycine was preferable at this position. A
mong synthesized cyclic pentapeptides, compound 36 (BQ-518) was the mo
st potent ETA receptor antagonist, with a pA(2) of 8.1 against ET-1-in
duced vasoconstriction in isolated porcine coronary arteries. This com
pound also showed the greatest selectivity between ET(A) and ET(B) rec
eptors (IC50 for human ET(A) = 1.2 nM, IC50 for human ET(B) = 55 mu M)
In contrast, compound 8 (BQ-123) is a highly soluble, potent, and sel
ective ETA receptor antagonist (pA(2) = 7.4, IC50 for human ET(A) = 8.
3 nM, IC50 for human ET(B) = 61 mu M). The sodium salt of 8 is practic
ally freely soluble in saline. These compounds are useful tools for no
t only in vitro but also in vivo pharmacological studies.